Finance

Lists
Why is AKTX down 8.35%?
Dive Deeper
AKTX:NASDAQ
Akari Therapeutics PLC
$7.24
-8.35%
(-0.66) 1D
$7.96
+9.94% (+0.72)
After hours
Closed: Oct 14, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AKTX...
Open
$8.10
High
$8.10
Low
$7.19
Mkt. cap
16.54M
Avg. vol.
69.48K
Volume
34.94K
52-wk high
$39.64
52-wk low
$3.02
EPS
-$330.40
Beta
1.43
Shares outstanding
1.14M
No. of employees
5
Open
$8.10
High
$8.10
Low
$7.19
Mkt. cap
16.54M
Avg. vol.
69.48K
Volume
34.94K
52-wk high
$39.64
52-wk low
$3.02
EPS
-$330.40
Beta
1.43
Shares outstanding
1.14M
No. of employees
5
News stories
From web sources and news partners
About Akari Therapeutics PLC
CEO-
Employees5
Founded2004
HeadquartersTampa, Florida, United States
SectorBiotechnology
Websiteakaritx.com
Analyst ratings
Based on 3 analysts giving stock ratings to AKTX in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AKTX in the last 3 months.
Highest
Current $7.24
$30.00 (+314.36%)
Average
$25.50 (+252.21%)
Lowest
$19.50 (+169.34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
$27.00
+272.9%
10/01/2026
Matthew Venezia
Alliance Global Partners
Buy
Reiterated
$19.50
+169.3%
09/16/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$30.00
+314.4%
08/18/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
$40.00
+452.5%
01/05/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$7.00
-3.3%
11/19/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
249.00K
1.09M
1.46M
2.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.98M
2.14M
2.17M
2.52M
Operating expense
2.22M
3.23M
3.63M
4.60M
Total operating expenses
2.22M
3.23M
3.63M
4.60M
Operating income
-2.22M
-3.23M
-3.63M
-4.60M
Other non operating income
253.00K
3.20M
274.00K
-99.00K
EBT including unusual items
-7.49M
-5.21M
-15.31M
-4.81M
EBT excluding unusual items
-2.12M
-998.00K
-3.35M
-4.81M
Income tax expense
-1.09M
85.00K
-859.00K
-
Effective tax rate
14.53%
-1.63%
5.61%
-
Other operating expenses
-
-
-
-
Net income
-6.40M
-5.30M
-14.46M
-4.81M
Net profit margin
-
-
-
-
Earnings per share
-1.06
-
-
-
Interest and investment income
1.00K
-
-
-
Interest expense
-121.00K
-723.00K
-61.00K
-80.00K
Net interest expenses
-120.00K
-723.00K
-61.00K
-80.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.22M
-3.22M
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps